Might 24, 2024 – An 82-year-old lady from Elliottsburg, Pennsylvania with aortic stenosis grew to become the primary individual on the planet to endure a brand new sort of transcatheter aortic valve alternative (TAVR) at UPMC Harrisburg. The affected person has been discharged and is recovering effectively. Hemal Gada, MD, president of the UPMC Coronary heart and Vascular Institute in Central Pa. carried out the process utilizing the FDA-approved next-generation Evolut™ FX+ TAVR system for the therapy of symptomatic extreme aortic stenosis. Dr. Gada is the primary interventional heart specialist on the planet to make use of this newest Evolut FX+ TAVR system.

The most recent Evolut FX+ TAVR system retains the valve efficiency advantages of the older Evolut TAVR platform, however permits for bigger coronary entry home windows by way of a modified diamond body design, which is 4 occasions bigger than earlier iterations of the Evolut TAVR system. Evolut FX+ gives higher room for catheter maneuverability to facilitate entry to coronary arteries.

Study extra